Dover has entered right into a definitive agreement to accumulate Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and control devices for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
Malema’s merchandise will expand Dover’s biopharma single-use manufacturing offering, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with amenities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in revenue during the full yr 2022.
When the deal closes, Malema will turn into a half of the PSG enterprise unit inside Dover’s Pumps & Process Solutions segment.
“We see an amazing long-term progress opportunity within the bioprocessing business pushed by a robust and rising pipeline of efficient novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more efficient single-use production processes helps a sturdy outlook for our offerings of single-use parts to end-customers. เกจ์อาร์กอนsumo consider that pairing Malema’s know-how with our current portfolio of single-use pumps for biopharma processing will tremendously enhance the accuracy and value proposition of our options to our prospects.”
“We are methodically building out our biopharma platform by way of proactive capability additions, new product development, and opportunistic acquisitions of highly-attractive niche part applied sciences,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing know-how and further strengthens our sensor portfolio with new proprietary technology. In addition to attractive biopharma purposes, we expect strong growth in the semiconductor house on the capacity expansion and re-shoring tailwinds.”
Share